13F HOLDINGS REPORT
MPM ASSET MANAGEMENT LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0000950123-24-005709
Total Value
$245.2M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Dyne Therapeutics, Inc. | DYN | 3,451,303 | $98.0M | 39.97% |
| 2 | Entrada Therapeutics, Inc. | TRDA | 4,425,784 | $62.7M | 25.58% |
| 3 | iTeos Therapeutics, Inc. | 46565G104 | 2,738,785 | $37.4M | 15.24% |
| 4 | Werewolf Therapeutics, Inc. | HOWL | 4,284,172 | $27.8M | 11.32% |
| 5 | Repare Therapeutics, Inc. | 760273102 | 2,242,636 | $10.6M | 4.31% |
| 6 | Adaptimmune Therapeutics plc | ADTI | 5,555,461 | $8.8M | 3.58% |